NEW YORK, Jan. 16, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

https://static.prnasia.com/pro/fec/jwplayer-7.12.1/jwplayer.js jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   NYSE Content Advisory: Pre-Market Update + Singapore Software Firm TechCreate Rings NYSE Bell after IPO jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2863513/NYSE_Market_Update_Jan_16.mp4’, image: ‘https://mma.prnasia.com/media2/2863513/NYSE_Market_Update_Jan_16.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on January 16th

Equities are higher this morning, lifted by tech enthusiasm, with chipmakers leading gains after Taiwan Semiconductor’s upbeat outlook and news of a U.S.–Taiwan trade deal involving at least $250B in Taiwanese chip and tech investment in U.S. production The stock rally is broadening, as the small‑cap Russell 2000 climbs too; experts say more stocks could benefit in the new year thanks to continued economic resilience. Tune in to NYSE Live at 9 a.m. ET as Tech‑Create Group celebrates its NYSE American IPO; CEO Heng Hai Lim will join to discuss the company’s real‑time payments, digital banking, and cybersecurity solutions.

Opening BellTechCreate Group celebrates its recent IPO

Closing BellLegendary New York Knicks Alumni tip-off the franchise’s Alumni Homecoming Weekend

Click here to download the NYSE TV App 

Video – https://mma.prnasia.com/media2/2863513/NYSE_Market_Update_Jan_16.mp4

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Forging new bonds with the Greater Bay Area

BEIJING, June 30, 2025 /PRNewswire/ — A news report from Beijing Review:…

GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

Integrates ToolGen’s best-in-class CRISPR-Cas9 platform with GenEditBio’s industry-leading lipid nanoparticle (LNP) delivery…

The First Hong Kong Embodied AI Industry Summit and AGIBOT Partner Conference 2026 Hong Kong Opens

AGIBOT unveils Hong Kong industry co-creation plan, international R&D headquarters initiative, and…